follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Quest completes $300M sale of business unit

By

Back to Top Comments Email Print

Latest News

    advertisement

    Madison-based Quest Diagnostics announced Tuesday it has completed the sale of its HemoCue diagnostic products business to Radiometer Medical ApS for approximately $300 million, plus adjustments for cash balances.

    According to the announcement, HemoCue develops, produces and markets hemoglobin, glucose and other point-of-care testing systems worldwide.

    In February, Quest announced it had agreed to sell HemoCue to Radiometer, with plans to use the proceeds to repurchase shares as part of a stock buyback program.

    Share This Story On:

    Write to the Editorial Department at editorial@njbiz.com

    advertisement

    Comments


    Be the first to comment.



    Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

    Post Comment
         View Comment Policy

    Advanced search
    Sponsored by
    advertisement
      
      
    advertisement
      
      
    advertisement
    Back to Top